Concepedia

Author

J A Hank

University of Wisconsin–Madison

Also Known As

J A Hank, J. A. Hank, Jackie A Hank, Jackie A. Hank

11

Publications

447

Citations

7

H-Index

29

Concepts

All Affiliations

University of Wisconsin–Madison
JA

About

J A Hank is an author at University of Wisconsin–Madison specializing in inflammation, medicine, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

297

2

Allergy

3

3

139

3

Health Sciences

1

1

158

4

Cell Biology

1

1

30

5

Clinical Immunology

1

1

28

J A Hank

×

6

Publications

425

Citations

6

H-Index

YearCitations

Clinical and immunological effects of recombinant interleukin 2 given by repetitive weekly cycles to patients with cancer.

Paul M. Sondel, Peter Köhler, J A Hank,

PubMed

1988

158

Repetitive Weekly Cycles of Interleukin-2. II. Clinical and Immunologic Effects of Dose, Schedule, and Addition of Indomethacin

Jeff Sosman, Peter Köhler, J A Hank,

JNCI Journal of the National Cancer Institute

1988

109

In vivo induction of the lymphokine-activated killer phenomenon: interleukin 2-dependent human non-major histocompatibility complex-restricted cytotoxicity generated in vivo during administration of human recombinant interleukin 2.

J A Hank, Peter Köhler, G Weil-Hillman,

PubMed

1988

81

Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype.

G Weil-Hillman, Stephan D. Voss, Paul Fisch,

PubMed

1990

30

Distinct clinical and laboratory activity of two recombinant interleukin-2 preparations.

J A Hank, Jean E. Surfus, J. Gan,

PubMed

1999

28

Specific Enzyme-Linked Immunosorbent Assays for Quantitation of Antibody-Cytokine Fusion Proteins

J. Gan, Kari Kendra, M. Ricci,

Clinical and Diagnostic Laboratory Immunology

1999

19

Page 1